XML 14 R7.htm IDEA: XBRL DOCUMENT v3.26.1
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
6 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Cash flows from operating activities:    
Net Income (Loss) $ 757,241 $ 244,876
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 49,990 51,263
Amortization of right-of-use lease assets 17,728 16,165
Stock-based compensation 126,466 107,363
Gain on divestiture of businesses (464,602) 0
Other non-cash items, net (2,052) 1,903
Changes in operating assets and liabilities, excluding the effects of acquisitions:    
Accounts receivable 135,414 127,972
Accounts payable and accrued expenses 81,706 (35,405)
Accrued compensation and benefits (37,897) (15,301)
Deferred revenue (48,648) 34,532
Accrued income taxes 108,888 5,565
Other current assets and prepaid expenses (145,805) (7,735)
Operating lease liabilities 12,414 (2,596)
Other noncurrent assets and liabilities (181) (8,864)
Net cash provided by operating activities 590,662 519,738
Cash flows from investing activities:    
Additions to property and equipment (5,011) (5,575)
Settlement of net investment hedges 16,706 12,260
Divestiture of businesses 523,306 0
Net cash provided by investing activities 535,001 6,685
Cash flows from financing activities:    
Borrowings under credit facility 76,250 860,000
Repayments of Senior Notes 0 (500,000)
Repayments of borrowings under credit facility (76,250) (720,125)
Repurchases of common stock (826,159) (150,000)
Proceeds from issuance of common stock 13,162 13,307
Payments of withholding taxes in connection with stock-based awards (52,816) (52,871)
Other financing activity (1,007) (1,410)
Net cash used in financing activities (866,820) (551,099)
Effect of exchange rate changes on cash, cash equivalents, and restricted cash (4,146) (6,048)
Net change in cash, cash equivalents, and restricted cash 254,697 (30,724)
Cash, cash equivalents, and restricted cash, beginning of period 184,988 266,466
Cash, cash equivalents, and restricted cash, end of period 439,685 235,742
Supplemental disclosure of non-cash financing and investing activities:    
Operating right-of-use assets obtained in exchange for operating lease liabilities $ 25,770 $ 11,294